367 related articles for article (PubMed ID: 31300508)
1. Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies.
Richardson M; Kirkham JJ; Dwan KM; Sloan DJ; Davies G; Jorgensen A
BMJ Open; 2019 Jul; 9(7):e030212. PubMed ID: 31300508
[TBL] [Abstract][Full Text] [Related]
2. STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline.
Chaplin M; Kirkham JJ; Dwan K; Sloan DJ; Davies G; Jorgensen AL
PLoS Med; 2020 Sep; 17(9):e1003344. PubMed ID: 32956352
[TBL] [Abstract][Full Text] [Related]
3. COS-STAR: a reporting guideline for studies developing core outcome sets (protocol).
Kirkham JJ; Gorst S; Altman DG; Blazeby J; Clarke M; Devane D; Gargon E; Williamson PR;
Trials; 2015 Aug; 16():373. PubMed ID: 26297658
[TBL] [Abstract][Full Text] [Related]
4. [Strengthening the Reporting of Pharmacogenetic Studies (STROPS) guideline].
Lu XR; Lai XF; Sun F; Zhan SY; Wang S
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 May; 43(5):747-754. PubMed ID: 35589583
[TBL] [Abstract][Full Text] [Related]
5. Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE).
Imran M; Kwakkenbos L; McCall SJ; McCord KA; Fröbert O; Hemkens LG; Zwarenstein M; Relton C; Rice DB; Langan SM; Benchimol EI; Thabane L; Campbell MK; Sampson M; Erlinge D; Verkooijen HM; Moher D; Boutron I; Ravaud P; Nicholl J; Uher R; Sauvé M; Fletcher J; Torgerson D; Gale C; Juszczak E; Thombs BD
BMJ Open; 2021 Apr; 11(4):e049093. PubMed ID: 33926985
[TBL] [Abstract][Full Text] [Related]
6. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.
Gates M; Gates A; Pieper D; Fernandes RM; Tricco AC; Moher D; Brennan SE; Li T; Pollock M; Lunny C; Sepúlveda D; McKenzie JE; Scott SD; Robinson KA; Matthias K; Bougioukas KI; Fusar-Poli P; Whiting P; Moss SJ; Hartling L
BMJ; 2022 Aug; 378():e070849. PubMed ID: 35944924
[TBL] [Abstract][Full Text] [Related]
7. Standardised method for reporting exercise programmes: protocol for a modified Delphi study.
Slade SC; Dionne CE; Underwood M; Buchbinder R
BMJ Open; 2014 Dec; 4(12):e006682. PubMed ID: 25550297
[TBL] [Abstract][Full Text] [Related]
8. A reporting guideline for clinical platelet transfusion studies from the BEST Collaborative.
Meyer E; Delaney M; Lin Y; Morris A; Pavenski K; Tinmouth A; Murphy M; Slichter SJ; Heddle N; Dumont LJ
Transfusion; 2013 Jun; 53(6):1328-34. PubMed ID: 23003345
[TBL] [Abstract][Full Text] [Related]
9. PRISMA-Children (C) and PRISMA-Protocol for Children (P-C) Extensions: a study protocol for the development of guidelines for the conduct and reporting of systematic reviews and meta-analyses of newborn and child health research.
Kapadia MZ; Askie L; Hartling L; Contopoulos-Ioannidis D; Bhutta ZA; Soll R; Moher D; Offringa M
BMJ Open; 2016 Apr; 6(4):e010270. PubMed ID: 27091820
[TBL] [Abstract][Full Text] [Related]
10. Protocol for the development of a reporting guideline for umbrella reviews on epidemiological associations using cross-sectional, case-control and cohort studies: the Preferred Reporting Items for Umbrella Reviews of Cross-sectional, Case-control and Cohort studies (PRIUR-CCC).
Solmi M; Cobey K; Moher D; Ebrahimzadeh S; Dragioti E; Shin JI; Radua J; Cortese S; Shea B; Veronese N; Hartling L; Pollock M; Egger M; Papatheodorou S; Ioannidis JP; Carvalho AF
BMJ Open; 2024 Jun; 14(6):e071136. PubMed ID: 38889936
[TBL] [Abstract][Full Text] [Related]
11. Protocol for the development of the Chatbot Assessment Reporting Tool (CHART) for clinical advice.
CHART Collaborative
BMJ Open; 2024 May; 14(5):e081155. PubMed ID: 38772889
[TBL] [Abstract][Full Text] [Related]
12. Development of the CLARIFY (CheckList stAndardising the Reporting of Interventions For Yoga) guidelines: a Delphi study.
Ward L; Nault D; Cramer H; Moonaz S
BMJ Open; 2022 Jan; 12(1):e054585. PubMed ID: 35105638
[TBL] [Abstract][Full Text] [Related]
13. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
McInnes MDF; Moher D; Thombs BD; McGrath TA; Bossuyt PM; ; Clifford T; Cohen JF; Deeks JJ; Gatsonis C; Hooft L; Hunt HA; Hyde CJ; Korevaar DA; Leeflang MMG; Macaskill P; Reitsma JB; Rodin R; Rutjes AWS; Salameh JP; Stevens A; Takwoingi Y; Tonelli M; Weeks L; Whiting P; Willis BH
JAMA; 2018 Jan; 319(4):388-396. PubMed ID: 29362800
[TBL] [Abstract][Full Text] [Related]
14. The Randomized Controlled Trials Rehabilitation Checklist: Methodology of Development of a Reporting Guideline Specific to Rehabilitation.
Negrini S; Armijo-Olivo S; Patrini M; Frontera WR; Heinemann AW; Machalicek W; Whyte J; Arienti C;
Am J Phys Med Rehabil; 2020 Mar; 99(3):210-215. PubMed ID: 31851008
[TBL] [Abstract][Full Text] [Related]
15. Preferred Reporting Items for Overviews of Reviews (PRIOR): a protocol for development of a reporting guideline for overviews of reviews of healthcare interventions.
Pollock M; Fernandes RM; Pieper D; Tricco AC; Gates M; Gates A; Hartling L
Syst Rev; 2019 Dec; 8(1):335. PubMed ID: 31870434
[TBL] [Abstract][Full Text] [Related]
16. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a consensus definition for mesenchymal stromal cells (MSC) and reporting guidelines for clinical trials of MSC therapy: a modified Delphi study protocol.
Renesme L; Cobey KD; Le M; Lalu MM; Thebaud B
BMJ Open; 2021 Oct; 11(10):e054740. PubMed ID: 34620674
[TBL] [Abstract][Full Text] [Related]
18. Development of the Anatomical Quality Assurance (AQUA) checklist: Guidelines for reporting original anatomical studies.
Tomaszewski KA; Henry BM; Kumar Ramakrishnan P; Roy J; Vikse J; Loukas M; Tubbs RS; Walocha JA
Clin Anat; 2017 Jan; 30(1):14-20. PubMed ID: 27801507
[TBL] [Abstract][Full Text] [Related]
19. Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design.
Dimairo M; Coates E; Pallmann P; Todd S; Julious SA; Jaki T; Wason J; Mander AP; Weir CJ; Koenig F; Walton MK; Biggs K; Nicholl J; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG
BMC Med; 2018 Nov; 16(1):210. PubMed ID: 30442137
[TBL] [Abstract][Full Text] [Related]
20. Essential items for reporting of scaling studies of health interventions (SUCCEED): protocol for a systematic review and Delphi process.
Gogovor A; Zomahoun HTV; Ben Charif A; McLean RKD; Moher D; Milat A; Wolfenden L; Prévost K; Aubin E; Rochon P; Ekanmian G; Sawadogo J; Rheault N; Légaré F
Syst Rev; 2020 Jan; 9(1):11. PubMed ID: 31926555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
